Nucleic Acid Complexes for High-Throughput Compound Screening
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening compounds for specific binding activities to targets, particularly for identifying compounds that induce allosteric changes or bind specifically to targets while distinguishing from related family members, are inefficient and lack precision.
Innovation Solution
The use of nucleic acid complexes, such as DNA nanoswitches, conjugated with candidate ligands bearing unique barcodes, allows for the identification of compounds that bind to targets and induce allosteric changes by physically separating bound and unbound complexes through gel electrophoresis, enabling high-throughput screening and sequencing of active compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional compound screening methods are used, then the process can be performed with simple equipment, but the identification precision of compounds inducing allosteric changes or binding specifically to targets is insufficient
Solution Approach 1:
The patent uses nucleic acid complexes as intermediary carriers that link candidate ligands to targets. These complexes serve as mediators in the screening process, enabling specific binding detection through barcode reading. The nucleic acid complex acts as an intermediary that translates biological binding events into detectable signals, thereby improving identification precision without requiring direct observation of the ligand-target interaction.
Solution Approach 2:
The patent employs barcode sequences as informational copies that encode the identity of candidate ligands. Instead of directly detecting the ligand structure, the system uses nucleic acid barcodes as copies or representations of the ligand identity. This copying approach allows high-precision identification through sequencing techniques, separating the detection function from the actual binding event.
2Productivity
If conventional screening methods are used, then the equipment requirements are minimal, but the throughput and efficiency of compound identification is low
Solution Approach 1:
The patent merges multiple functions into the nucleic acid complex system: the complex simultaneously carries the candidate ligand, provides binding information through target interaction, and stores identification data through barcode sequences. This merging of functions enables high-throughput screening by processing multiple compounds in parallel, as each nucleic acid complex can be independently handled and identified through sequencing, significantly reducing screening time.
Solution Approach 2:
The patent replaces traditional mechanical or manual screening methods with nucleic acid-based molecular recognition and sequencing. Instead of physically separating and manually analyzing compounds, the system uses nucleic acid hybridization and sequencing to identify binding events. This substitution of detection mechanisms dramatically increases throughput and reduces the time required for compound screening.
3Measurement precision
If standard binding assays are used, then the assay format is simple, but the ability to distinguish target-specific binding from binding to related family members is insufficient
Solution Approach 1:
The patent segments the screening process into distinct functional components: the nucleic acid complex contains separate elements for target binding (through linked targets), ligand identification (through barcodes), and decoy binding control. This segmentation allows the system to simultaneously assess binding to the target protein and binding to decoy proteins with related family members, providing high specificity through modular functional separation.
Solution Approach 2:
The patent creates composite nucleic acid complexes that integrate multiple functional elements: scaffold nucleic acids, oligonucleotide linkers, barcode sequences, and target proteins. These composite structures enable simultaneous performance of binding assays and identification functions, allowing distinction between target-specific binding and binding to family members through the integrated design of the composite system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient identification of compounds that bind specifically to targets, induce allosteric changes, and distinguish between target and decoy proteins, enhancing the precision and throughput of compound screening processes.
Implementation Method 1
allows for the identification of compounds that bind to targets and induce allosteric changes by physically separating bound and unbound complexes through gel electrophoresis
Data Source
AI summary
The invention provides compositions comprising nucleic acid complexes for use in screening compounds based on their ability to modulate binding interactions, wherein the compounds are barcoded.